Glycopath was founded with the goal of revolutionizing biomarker research using glycomics and imaging mass spectrometry workflows. Our mission is to generate efficient and effective prognostic platforms for serum and tissue detection of disease based on glycosylation profiles using MALDI imaging MS. Our Basic N-Glycan Imaging kit provides researchers with the necessary components and protocols to perform tissue N-Glycan IMS on their projects allowing for deeper investigations into the molecular basis of disease through glycomic analysis.